Utilizing Bacteria-Derived Components for Cancer Immunotherapy
news

Utilizing Bacteria-Derived Components for Cancer Immunotherapy

BIO Integration (BIOI) announces the publication of a new article https://doi.org/10.15212/bioi-2022-0022.

BIOI focuses on original, cutting-edge, interdisciplinary contents in the field of biosciences, including medicine, biochemistry, biophysics, bioengineering, biotechnology, etc., which generate hypotheses and questions relevant to the patient and disease and guide the investigations of cellular and molecular medicine.

BIOI welcomes the submission of review articles; original research; news/commentaries/editorials on specific topics of interest to the readership; short communications/technical reports which can include works-in-progress, short reports, and technical notes; “How I Do It” articles covering the technical aspects of a procedure and case reports that should provide a brief description of a case with unique features that have been previously unreported.

Submissions to BIOI are made using ScholarOne, the online submission and peer review system. Registration and access are available here.

Follow BIOI on Twitter @JournalBio; Facebook (https://www.facebook.com/BIO-Integration-Journal-108140854107716/) and LinkedIn (https://www.linkedin.com/company/bio-integration-journal/).